THE PREVENT TRIAL
Stopping Lymphedema Starts with PREVENT - Final 3-Year Primary Endpoint Results Published

New Data Evaluating ImpediMed’s SOZO® in Heart Failure Patients to be Presented at Heart Failure Society of American Annual Scientific Meeting 2022